Back to Insights

Mapping U.S.-China Exposure: A Strategic Imperative for the Board

Brian B. Su, Artisan Business Group · 20+ years U.S.–Asia advisory

In my experience, boards often mistake a static risk briefing for a dynamic exposure map, leaving them vulnerable to structural shifts in the U.S.-China relationship. This article outlines a four-dimensional framework to quantify your firm's true concentration risk and drive decisive action on supply chain resilience and compliance.

Why Boards Need an Exposure Map, Not a Briefing

I tell clients that a risk briefing is a snapshot of the past, but an exposure map is a navigation tool for the future. Many boards receive quarterly updates on geopolitical headlines, yet they lack a granular understanding of how those headlines translate into P&L volatility. In my experience, if your board cannot identify the specific percentage of COGS dependent on China-based production or the exact number of sole-source components manufactured there, you are not managing risk. You are performing risk management theater. An exposure map forces the organization to move beyond high-level sentiment and into the mechanics of the business. It identifies where your company is structurally tethered to China, whether through Tier-3 suppliers, financial assets, or critical end-market revenue. By visualizing these dependencies, the board can shift from reactive crisis management to proactive strategic positioning.

The Four Dimensions of Exposure

To build a robust map, I recommend evaluating your business across four distinct dimensions. First, the regulatory dimension covers the evolving landscape of the Uyghur Forced Labor Prevention Act, BIS Entity Lists, and the 1260H List, which have transformed compliance from administrative overhead into a supply chain gating mechanism. Second, the commercial dimension assesses your reliance on China as both a production base and a key end market. Third, the financial dimension requires stress testing your balance sheet against potential impairments of WFOEs or JVs and the working capital impact of a 90-day shipping disruption. Finally, the operational dimension focuses on your Time to Recover and Time to Survive. If your secondary suppliers are only qualified on paper rather than operationally proven, your operational continuity is an illusion. These four pillars provide the granularity necessary to distinguish between manageable friction and existential threats.

Quantifying the Taiwan Contingency

The Taiwan question is the most significant tail risk for any firm with China exposure. While we cannot predict the timing of a conflict, we can quantify the impact. I advise boards to treat a Taiwan Strait disruption as a base case for stress testing. With over 2.4 trillion dollars in annual sea shipments passing through this waterway, a conflict would trigger immediate insurance spikes and logistics bottlenecks. You must ask: what is the impact on your critical inputs if the Strait is restricted? Since Taiwan produces 92 percent of the world's advanced semiconductor chips, your map must identify which of your products rely on these components. If you cannot operate for more than a few months without these resources, your board must decide now whether to stockpile, diversify, or accept the risk. This is not about predicting war, but about quantifying the cost of a total supply chain severance.

Driving Board-Level Decisions

Once the map is built, it must drive action. I use the exposure map to guide three specific board decisions. First, hedging: if the map reveals high concentration, the board must authorize capital for geographic diversification, even if it increases short-term costs. Second, supply-chain transitions: the map identifies which components are truly critical, allowing management to prioritize the qualification of alternative suppliers in allied nations. Third, compliance investments: with the U.S. government monitoring hundreds of mitigation agreements and expanding restricted party lists, the board must ensure that in-house counsel has the resources to maintain rigorous, automated compliance structures. If your exposure map shows that more than 50 percent of your COGS or revenue is China-dependent, the board has a fiduciary duty to move beyond status quo assumptions and mandate a structural reduction in concentration risk.

Frequently Asked Questions

How do we know if our current risk management is just 'theater'?

If your inventory policy for China-sourced critical components mirrors that of non-critical inputs, or if your secondary suppliers are only qualified on paper rather than operationally proven, you are likely in the theater category. A real strategy requires proven, alternative production capacity that can be activated within your defined Time to Survive.

What is the most common mistake boards make when assessing China risk?

The most common mistake is treating geopolitical risk as a binary event where all firms are impacted equally. Boards often fail to map risks to specific business functions, leading to a lack of accountability. You must assign ownership of these risks to specific business unit leaders who understand how regulatory or supply chain shifts affect their specific P&L.

Need advisory on Geopolitical Risk Advisory?

Brian B. Su works directly with decision-makers.

Related Articles